FINAL DEVELOPMENT SAMPLING Sample Clauses

FINAL DEVELOPMENT SAMPLING. BBC shall then develop and produce final development samples of the Stage III Products selected by LAG and shall produce, or cause to be produced, at least two (2) pairs of final development samples of each such Stage III Product, and shall deliver one pair to LAG for its review and approval and shall retain one pair for BBC's own reference. Concurrently with its delivery of each final development sample to LAG pursuant to this Section 3(d), BBC shall deliver to LAG a fully completed FCA price confirmation memo, in the form attached hereto as Exhibit C (the "Price Confirmation Memo"), setting forth the FCA price, by factory and country, of such Stage III Product, and the production volume and size range upon which such FCA price is based, and shall be accompanied by detailed cost breakdown sheets for each such Stage IV Product from the factory proposed by BBC to manufacture such Product, setting forth the projected cost of each component thereof, its manufacturing, assembly, packaging and freight cost for shipment to LAG's consolidator ("Cost Breakdown Sheets"), together with detailed computerized specification sheets, in the form attached hereto as Exhibit D, complete as to each and every material feature, part, component, fabrication method, weight breakdown, required box size, and color description and codes based on LAG's approved color list and referenced to the Pantone color system ("Specification Sheets"), developed for such Stage III Product; PROVIDED, HOWEVER, that (i) if such Price Confirmation Memo (x) is for a Product style that would constitute any EEC quota style (only where applicable) and (y) identifies the People's Republic of China as the proposed country-of-origin, then BBC shall deliver a second fully completed Price Confirmation Memo for such Product style (together with the corresponding Cost Breakdown Sheets and Specification Sheets) which sets forth a country-of-origin other than the People's Republic of China; and (ii) the proposed manufacturer of such Product, and the proposed supplier of the lighted technology to be contained therein, must be acceptable to LAG in its sole discretion. LAG shall then (i) review the final development samples, (ii) select those Stage III Products for which it wishes to make sales samples ("Stage IV Product"), and (iii) provide BBC with its comments and/or instructions as to the changes or modifications, if any, that it desires to be made for the sales samples of such Stage IV Products.
AutoNDA by SimpleDocs

Related to FINAL DEVELOPMENT SAMPLING

  • Clinical Development (a) Stellartech shall design, develop and construct a Clinical Unit for each of the Thermage Disposable Device and the Thermage Generator, and any required component or subassembly thereof and shall deliver such Clinical Units to Thermage in accordance with the Development Program; (b) Stellartech shall deliver to Thermage such other Deliverables as are contemplated by the Development Program in accordance with the Development Program; and (c) as requested by Thermage and automatically at the conclusion of the Development Program, Stellartech, so long as Thermage is not in breach of its material obligation hereunder, shall deliver in writing to Thermage any and all data and information held by or in the control of Stellartech which is necessary or useful to obtain regulatory approval of the Products in the United States or any foreign country.

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

  • Development Plan As defined in Section 3.2(a).

  • Development Activities NovaDel shall not be required to commence any Development Activities until Licensee has paid at least twenty-five percent (25%) of the non-refundable License Fee described in Section 4.4.

  • Commercialization Reports After the First Commercial Sale of a Licensed Product anywhere in the Territory, LICENSEE shall submit to Cornell semi-annual reports on or before each February 28 and August 31 of each year. Each report shall cover LICENSEE’s (and each Affiliate’s and Sublicensee’s) most recently completed calendar half-year and shall show:

  • Development Program A. Development Activities to be Undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Development Diligence Pfizer will use its Commercially Reasonable Efforts to Develop and seek Regulatory Approval for [ * ] Product [ * ] in the Field [ * ]. Pfizer will [ * ] with respect to the Development or Regulatory Approval of Products under this Agreement.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development Plans 4.3.1 For each Licensed Indication and corresponding Licensed Product in the Field, Licensee will prepare and deliver to Licensor a development plan and budget (each a “Development Plan”). The initial Development Plans for each Licensed Indication will be delivered within […***…] after the Grant Date for such Licensed Indication.

  • Development Work Do, or cause to be done, such development and other work as may be reasonably necessary to protect from diminution and production capacity of the Mortgaged Property and each producing well thereon.

Time is Money Join Law Insider Premium to draft better contracts faster.